(E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide

C30H32N6O2 — CID 6047140

IUPAC(E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide
SMILESCc1cc(N2CCN(c3ncccn3)CC2)nc2ccc(NC(=O)/C=C/c3ccccc3OC(C)C)cc12
InChIInChI=1S/C30H32N6O2/c1-21(2)38-27-8-5-4-7-23(27)9-12-29(37)33-24-10-11-26-25(20-24)22(3)19-28(34-26)35-15-17-36(18-16-35)30-31-13-6-14-32-30/h4-14,19-21H,15-18H2,1-3H3,(H,33,37)/b12-9+
InChIKeyXNBNYWSXBWNQEZ-FMIVXFBMSA-N
MW508.63 g/mol
LogP5.10
Rot. Bonds7

About (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide

(E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide (PubChem CID 6047140) has the molecular formula C30H32N6O2 and a molecular weight of 508.63 g/mol. Its IUPAC name is (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide.

Molecular Properties

Compound Name(E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide
PubChem CID6047140
Molecular FormulaC30H32N6O2
Molecular Weight508.63 g/mol
Exact Mass508.26
IUPAC Name(E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide
SMILESCc1cc(N2CCN(c3ncccn3)CC2)nc2ccc(NC(=O)/C=C/c3ccccc3OC(C)C)cc12
InChIInChI=1S/C30H32N6O2/c1-21(2)38-27-8-5-4-7-23(27)9-12-29(37)33-24-10-11-26-25(20-24)22(3)19-28(34-26)35-15-17-36(18-16-35)30-31-13-6-14-32-30/h4-14,19-21H,15-18H2,1-3H3,(H,33,37)/b12-9+
InChIKeyXNBNYWSXBWNQEZ-FMIVXFBMSA-N
XLogP5.10
TPSA83.48 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500508.63
LogP ≤ 55.10
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'ene_one_A(3)', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide?
The IUPAC name of (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide (CID 6047140) is (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide.
What is the SMILES notation for (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide?
The canonical SMILES for (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide is Cc1cc(N2CCN(c3ncccn3)CC2)nc2ccc(NC(=O)/C=C/c3ccccc3OC(C)C)cc12.
What is the InChIKey of (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide?
The InChIKey is XNBNYWSXBWNQEZ-FMIVXFBMSA-N. The full InChI is InChI=1S/C30H32N6O2/c1-21(2)38-27-8-5-4-7-23(27)9-12-29(37)33-24-10-11-26-25(20-24)22(3)19-28(34-26)35-15-17-36(18-16-35)30-31-13-6-14-32-30/h4-14,19-21H,15-18H2,1-3H3,(H,33,37)/b12-9+.
What are the key properties of (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide?
(E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide has a molecular weight of 508.63 g/mol, XLogP of 5.10, 7 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-N-[4-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)quinolin-6-yl]-3-(2-propan-2-yloxyphenyl)prop-2-enamide is sourced from PubChem (CID 6047140), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).